We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Enterprise Financial Services Corp
EFSC
$2.4B
| $5.08M | 0.07% |
124,694
+17,870
| +17% | +$768K |
|
327
Matrix Service
MTRX
$347M
| $5.08M | 0.07% |
259,505
+33,300
| +15% | +$680K |
|
328
NovoCure
NVCR
$1.97B
| $5.08M | 0.07% |
105,433
+17,970
| +21% | +$865K |
|
329
UMB Financial
UMBF
$10.7B
| $5.07M | 0.07% |
79,217
-7,415
| -9% | -$490K |
|
330
TriNet
TNET
$2.94B
| $5.04M | 0.07% |
84,449
+49,889
| +144% | +$2.63M |
|
331
Calix
CALX
$2.32B
| $4.98M | 0.07% |
647,086
+312,425
| +93% | +$2.75M |
|
|
DBD
332
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.93M | 0.07% |
+445,474
| New | +$3.11M |
|
|
TOWR
333
DELISTED
Tower International, Inc.
TOWR
| $4.91M | 0.07% |
233,566
+59,580
| +34% | +$1.53M |
|
|
NXRT
334
NexPoint Residential Trust
NXRT
$671M
| $4.89M | 0.07% |
127,547
+29,110
| +30% | +$1.07M |
|
335
Jack in the Box
JACK
$299M
| $4.88M | 0.07% |
60,250
+40,810
| +210% | +$3.26M |
|
336
Rambus
RMBS
$10.4B
| $4.86M | 0.07% |
465,138
+232,699
| +100% | +$2.23M |
|
337
Comfort Systems
FIX
$60.9B
| $4.82M | 0.07% |
92,009
+21,010
| +30% | +$1.05M |
|
338
Dollar Tree
DLTR
$24.1B
| $4.82M | 0.07% |
+45,860
| New | +$4.5M |
|
|
PRA
339
DELISTED
ProAssurance
PRA
| $4.79M | 0.07% |
138,268
+23,770
| +21% | +$962K |
|
340
RingCentral
RNG
$4.5B
| $4.78M | 0.07% |
44,322
-9,180
| -17% | -$902K |
|
341
UnitedHealth
UNH
$379B
| $4.78M | 0.07% |
19,322
-33,460
| -63% | -$8.53M |
|
|
CKH
342
DELISTED
Seacor Holdings Inc.
CKH
| $4.77M | 0.07% |
112,917
+18,030
| +19% | +$769K |
|
|
CLR
343
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.76M | 0.07% |
106,370
+41,870
| +65% | +$1.87M |
|
344
Group 1 Automotive
GPI
$4.01B
| $4.73M | 0.07% |
73,065
+7,940
| +12% | +$482K |
|
345
Target
TGT
$63.7B
| $4.72M | 0.07% |
58,850
-255,450
| -81% | -$18.7M |
|
346
HealthStream
HSTM
$814M
| $4.7M | 0.07% |
167,380
+48,450
| +41% | +$1.27M |
|
|
SRDX
347
DELISTED
Surmodics
SRDX
| $4.66M | 0.07% |
107,090
+35,250
| +49% | +$1.8M |
|
348
Live Nation Entertainment
LYV
$41.7B
| $4.65M | 0.07% |
+73,200
| New | +$4.15M |
|
|
PSDO
349
DELISTED
Presidio, Inc. Common Stock
PSDO
| $4.49M | 0.06% |
303,248
+268,873
| +782% | +$4.11M |
|
350
Qorvo
QRVO
$7.92B
| $4.41M | 0.06% |
61,510
+49,440
| +410% | +$3.27M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.